APOE and Alzheimer disease: Furthermore, higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration in AD, which provides evidence that sTREM2 may be protective against the development of AD (Franzmeier et al., 2020).